Literature DB >> 9438902

Relationship between lipid peroxidation and disease activity in patients with Behçet's disease.

A Orem1, H Efe, O Değer, G Cimşit, H A Uydu, B Vanizor.   

Abstract

Behçet's disease is a chronic multi-systemic disorder which is characterized by a relapsing systemic inflammatory process. The alteration of lipid profile and lipid peroxidation resulting from the inflammatory process may he associated with an increased risk for atherosclerosis in patients with Behcet's disease. We investigated lipids, lipoprotein and lipid peroxidation and their inter-relationships considering the disease activity. Eighteen patients (11 male and 7 female) and 20 age-matched healthy subjects (10 male and 10 female) were studied. Lipid profile including total cholesterol, triacylglycerol, HDL-cholesterol, LDL-cholesterol, lipoprotein(a), apoAI and apoB, and acute phase reactants including polymorphonuclear (PMN) elastase, PMN leukocyte count, erythrocyte sedimentation rate (ESR) and complements (C3, C4) were evaluated in patients in active and inactive periods of Behçet's disease and control subjects. The levels of thiobarbituric acid reactive substance (TBARS) were assessed as an indicator of lipid peroxidation. Lipid peroxidation was found to he increased in the active period compared to the inactive period of the disease and control subjects. Also, lipid peroxidation showed correlations of various degrees with atherogenic lipid parameters in both periods of the followed-up patients. In conclusion, patients with Behçet's disease in the active period may be much more susceptible to atherogenic events than those in the inactive period of the disease and control subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438902     DOI: 10.1016/s0923-1811(97)00613-0

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  4 in total

1.  Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

Authors:  Zeki Yesilova; Salih Pay; Cagatay Oktenli; Ugur Musabak; Kenan Saglam; S Yavuz Sanisoglu; Kemal Dagalp; M Kemal Erbil; Ismail H Kocar
Journal:  Rheumatol Int       Date:  2004-04-01       Impact factor: 2.631

2.  Serum paraoxonase activity is decreased in the active stage of Behçet's disease.

Authors:  S Karakucuk; G Baskol; A O Oner; M Baskol; E Mirza; M Ustdal
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

3.  Arterial distensibility as determined by carotid-femoral pulse wave velocity in patients with Behçet's disease.

Authors:  Turhan Kürüm; Mustafa Yildiz; Mehmet Soy; Gültaç Ozbay; Levent Alimgil; Binnur Tüzün
Journal:  Clin Rheumatol       Date:  2004-09-08       Impact factor: 2.980

4.  Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease.

Authors:  Fuat Cimen; Sembol Turken Yildirmak; Andac Ergen; Mustafa Cakmak; Serkan Dogan; Necati Yenice; Funda Sezgin
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.